دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry
Warkaa Shamkhani MBChB, Muhammad Rashid PhD, Mamas Mamas DPhil
doi : 10.1002/ccd.30366
Complex, high-risk percutaneous coronary intervention (PCI)Â (CHiP) is increasingly being undertaken in octogenarians. However, limited data exist on CHiP types, trends, and outcomes in the octogenarian.
CHIP-PCI: Ready for a prime time?
Giuseppe Tarantini MD, PhD, Francesco Cardaioli MD
doi : 10.1002/ccd.30466
Antegrade dissection and re-entry versus parallel wiring in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry
Bahadir Simsek MD, Spyridon Kostantinis MD, Judit Karacsonyi MD, PhD, Khaldoon Alaswad MD, Farouc A. Jaffer MD, PhD, Darshan Doshi MD, Sevket Gorgulu MD, Omer Goktekin MD, Jimmy Kerrigan MD, Elias Haddad MD, Stephane Rinfret MD, SM, Wissam A. Jaber MD, William Nicholson MD, Nidal Abi Rafeh MD, Salman Allana MD, Michalis Koutouzis MD, Yiannis Tsiafoutis MD, Emmanouil S. Brilakis MD, PhD, PROGRESS-CTO Investigators
doi : 10.1002/ccd.30346
The comparative efficacy and safety of parallel wiring versus antegrade dissection and re-entry (ADR) in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is controversial.
Radial access for chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry
Bahadir Simsek MD, Sevket Gorgulu MD, Spyridon Kostantinis MD, Judit Karacsonyi MD, PhD, Khaldoon Alaswad MD, Farouc A. Jaffer MD, PhD, Darshan Doshi MD, Omer Goktekin MD, Jimmy Kerrigan MD, Elias Haddad MD, Mitul Patel MD, Stephane Rinfret MD, SM, Wissam A. Jaber MD, William Nicholson MD, Nidal Abi Rafeh MD, Salman Allana MD, Michalis Koutouzis MD, Emmanouil S. Brilakis MD, PhD, PROGRESS-CTO investigators
doi : 10.1002/ccd.30347
Use of radial access for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has been increasing.
Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention
Hussein Bashar, Andrija Matetić, Nick Curzen, Mamas A. Mamas
doi : 10.1002/ccd.30404
Extracardiac vascular disease (ECVD) is increasingly recognized as a cardiovascular risk factor, but its association with outcomes after percutaneous coronary intervention (PCI) has not been well characterized.
Percutaneous coronary intervention in the polyvascular patient remains a high-risk procedure
John G. Winscott MD, William B. Hillegass MD, PhD
doi : 10.1002/ccd.30454
Outcomes and challenges of the provisional stenting technique: Insights from the PROGRESS-BIFURCATION registry
Bahadir Simsek MD, Spyridon Kostantinis MD, Judit Karacsonyi MD, PhD, Salman Allana MD, Evangelia Vemmou MD, Ilias Nikolakopoulos MD, Martin Nicholas Burke MD, Santiago Garcia MD, Yale Wang MD, Ivan Chavez MD, Mario Gössl MD, PhD, Paul Sorajja MD, Michael Mooney MD, Anil Poulose MD, Yader Sandoval MD, Jay Traverse MD, Bavana V. Rangan BDS, MPH, Emmanouil S. Brilakis MD, PhD
doi : 10.1002/ccd.30401
Provisional stenting is the most commonly used coronary bifurcation stenting strategy.
Retrograde approach for rewiring a jailed side branch during double kissing crush stenting
Tarek Chami MD, Madeline K. Mahowald MD, Emmanouil Brilakis MD, PhD
doi : 10.1002/ccd.30387
Double kissing crush (DK crush) is one of the preferred strategies for bifurcation stenting due to the lower risk of target vessel failure but can be difficult to perform. Difficulty in wiring the jailed side branch after stenting the main vessel is not uncommon. The retrograde crossing can provide a solution in selected cases when antegrade rewiring of a jailed side branch fails during DK crush (or other bifurcation stenting techniques).
Failure patterns after intravascular brachytherapy for in-stent coronary restenosis
Kent Wallner MD, Kathleen E. Kearney MD, Minsun Kim PhD, Jasleen Tiwana MD, David Elison MD, Edward Y. Kim MD, Upendra Parvathaneni MD, William L. Lombardi MD, Mark L. Phillips PhD, Creighton Don PhD, MD
doi : 10.1002/ccd.30399
One strategy to improve the effectiveness of intravascular brachytherapy (IVBT) is to study its failures. Previous investigations described mostly discrete, focal recurrences, typically at the proximal or distal edges of the irradiated segment after plain angioplasty or bare metal stents. We reviewed failure patterns of 30 unselected drug-eluting stent (DES) patients who had follow-up angiograms for recurrence within their IVBT-treated vessel.
How good is intravascular brachytherapy for treating in-stent restenosis?
Salman S. Allana MD, Emmanouil S. Brilakis MD, PhD
doi : 10.1002/ccd.30462
A comment and suggestion on angiography-derived FFR: NiFFR
Jianchang Xie MSc, Jinyu Huang MD, Guoxin Tong MD, Jianmin Yang MD
doi : 10.1002/ccd.30361
Ventricular arrhythmias following transcatheter pulmonary valve replacement with the harmony TPV25 device
Anne Taylor MD, Jeffrey Yang MD, Anne Dubin MD, Mark Henry Chubb MBBS, PhD, Kara Motonaga MD, Will Goodyer MD, PhD, Heather Giacone MD, Lynn Peng MD, Anitra Romfh MD, Doff McElhinney MD, Scott Ceresnak MD
doi : 10.1002/ccd.30393
Transcatheter pulmonary valve replacement (TPVR) with the Harmony valve (Medtronic, Inc.) was recently approved to treat postoperative native outflow tract pulmonary regurgitation. While the 22 mm Harmony valve Early Feasibility Study demonstrated ventricular tachycardia (VT) in only 5% of patients, little is known about ventricular arrhythmias after TPVR with the larger 25 mm valve (TPV25).
Atrial fibrillation after patent foramen ovale device closure: Protecting from one embolic stroke etiology but causing another?
Sanaullah Mojaddedi MD, Saliman Esmati MD, Nimesh K. Patel MD, Jonathan M. Tobis MD, Mohammad K. Mojadidi MD
doi : 10.1002/ccd.30330
Real-world VASCADE closure device versus manual compression use and outcomes in patients with severe common femoral artery disease
Sameer Nagpal MD, Lindsey E. Scierka MD, MPH, Yulanka Castro-Dominguez MD, Dhruv Kansal MD, Steffne Kunnirickal MD, Yasin Hussain MD, Keith Love MD, Edouard Aboian MD, Kim G. Smolderen PhD, Carlos Mena-Hurtado MD
doi : 10.1002/ccd.30405
The VASCADE closure device deploys an extravascular collagen plug. Its use in those with access site disease undergoing peripheral vascular intervention (PVI) is unknown. We aimed to evaluate the efficacy and safety of the VASCADE closure device compared to manual compression (MC) in patients with moderate femoral access site disease.
VASCADE closure device use in severe common femoral artery disease
Sardar H. Ijaz MD, Michael S. Levy MD, MPH
doi : 10.1002/ccd.30453
Zone 0 thoracic endovascular aortic repair in high risk patients: A retrospective case series
Yu-Tong Yen MD, Yen-Yang Chen MD, Patrick Hung-Ju Kao MD, Chia-Hsun Lin MD
doi : 10.1002/ccd.30356
To report our experience applying endovascular stent graft repair to treat ascending aortic diseases in high-risk patients and to evaluate the safety and feasibility of this approach. Patients with comorbid conditions or older age are not suitable for open procedures but may be considered suitable for ascending endovascular repair. Eleven high-risk patients received zone 0 thoracic endovascular aortic repair from September 2014 to May 2020.
Facilitation techniques to cross the interatrial septum with intracardiac echocardiography during left atrial appendage closure
Maarten Vanhaverbeke MD, PhD, Philippe Nuyens MD, Gintautas Bieliauskas MD, Lars Sondergaard MD, DMSc, Niels Vejlstrup MD, PhD, Ole De Backer MD, PhD
doi : 10.1002/ccd.30348
Usefulness of a novel sizing chart for left atrial appendage occlusion with the Amplatzer Amulet
Xavier Freixa MD, PhD, Pedro Cepas-Guillén MD, PhD, Kasper Korsholm MD, PhD, Anders Kramer MD, PhD, Ander Regueiro MD, PhD, Eduardo Flores-Umanzor MD, PhD, Laura Sanchis MD, PhD, Andrea Arenas-Loriente MD, PhD, Jesper Møller Jensen MD, PhD, Jens Erik Nielsen-Kudsk MD, PhD
doi : 10.1002/ccd.30406
The present article aims to compare a novel sizing chart based on both maximum and minimum diameters (novel MATRIX) with the current sizing recommendation instructions for use (IFU) based on the maximum diameter.
Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement
Toshiaki Isogai MD, MPH, Husitha Reddy Vanguru MD, Amar Krishnaswamy MD, Ankit Agrawal MD, Nikolaos Spilias MD, Shashank Shekhar MD, Anas M. Saad MD, Beni Rai Verma MD, Rishi Puri MBBS, PhD, Grant W. Reed MD, MSc, Zoran B. Popović MD, PhD, Shinya Unai MD, James J. Yun MD, PhD, Ken Uchino MD, Samir R. Kapadia MD
doi : 10.1002/ccd.30340
The cerebral embolic protection (CEP) device captures embolic debris during transcatheter aortic valve replacement (TAVR). However, the impact of CEP on stroke severity following TAVR remains unclear. Therefore, we aimed to examine whether CEP was associated with reduced severity of stroke following TAVR.
Bespoke valve sizing avoids annular rupture in patients treated with a balloon-expandable transcatheter heart valve
Jorge Chavarria MD, Felipe Falcao MD, Gustavo Dutra MD, Janarthanan Sathananthan MD, David Wood MD, Georgia Douvi MD, Madhu Natarajan MD, MSC, Iqbal Jaffer, James Velianou MD, Tej Sheth MD
doi : 10.1002/ccd.30402
Annular and left ventricular outflow tract (LVOT) calcification increase the risk of annular rupture following transcatheter aortic valve replacement (TAVR). The outcomes of a strategy of routine use of a balloon-expandable valve (BEV) for all patients irrespective of annular or LVOT calcium is unknown.
Procedural and long-term outcome among patients undergoing expedited trans-catheter aortic valve replacement
Anat Berkovitch MD, Amit Segev MD, Victor Guetta MD, Ariel Finkelstein MD, Ran Kornowski MD, Haim Danenberg MD, Paul Fefer MD, Hana Vaknin Assa MD, Maayan Konigstein MD, Ilan Merdler MD, Gidon Perlman MD, Elad Maor MD, PhD, Rivka Carmiel MD, David Planer MD, Ariel Banai MD, Mony Shuvy MD, Abid R. Assali MD, Katia Orvin MD, Israel M. Barbash MD
doi : 10.1002/ccd.30386
Patients with rapidly deteriorating clinical status due to severe aortic stenosis are often referred for expedited transcatheter aortic valve replacement (TAVR). Data regarding the outcome of such interventions is limited. We aimed to evaluate the outcome of patients undergoing expedited TAVR.
When possible, try to avoid emergent transcatheter aortic valve replacement
Lowell F. Satler MD
doi : 10.1002/ccd.30470
Impact of high-pressure balloon aortic valvuloplasty on the hydrodynamic result after a transcatheter valve-in-valve procedure
Najla Sadat MD, Denise Bruhn BSc, Michael Scharfschwerdt PhD, Tim Schaller MSc, Anas Aboud MD, Hiroyuki Saisho MD, Ingo Eitel MD, PhD, Stephan Ensminger MD, PhD, Buntaro Fujita MD
doi : 10.1002/ccd.30359
The aim of this study was to investigate the degree of functional improvement of a transcatheter heart valve (THV) for valve-in-valve after bioprosthetic valve fracture (BVF) of three small surgical aortic valve bioprostheses (SAVBP) using high-pressure balloon aortic valvuloplasty (HP-BAV) under standardized ex-vivo-conditions.
A simplified cardiac damage staging predicts the outcome of patients undergoing TAVR�A multicenter analysis
Jasmin Shamekhi MD, Caroline Hasse MD, Verena Veulemans MD, Baravan Al-Kassou MD, Kerstin Piayda MD, Oliver Maier MD, Tobias Zeus MD, Marcel Weber MD, Alexander Sedaghat MD, Sebastian Zimmer MD, Malte Kelm MD, Georg Nickenig MD, Jan-Malte Sinning MD
doi : 10.1002/ccd.30368
A significant number of patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) suffer from extra-aortic cardiac damage. Few studies have investigated strategies to quantify cardiac damage and stratify patients accordingly in different risk groups. The aim of this retrospective multicenter study was to provide a user-friendly simplified staging system based on the proposed classification system of Généreux et al. as a tool to evaluate the prognosis of patients undergoing TAVR more easily. Moreover, we analyzed changes in cardiac damage after TAVR.
Two-year outcomes after transcatheter aortic valve-in-valve implantation in degenerated surgical valves
Abdelrahman I. Abushouk MD, Omar Abdelfattah MD, Mohamed M. Gad MD, Anas Saad MD, Essa Hariri MD, MS, Toshiaki Isogai MD, Shashank Shekhar MD, Grant W. Reed MD, Rishi Puri MD, James Yun MD, Patrick R. Vargo MD, Aaron J. Weiss MD, PhD, Daniel Burns MD, Shinya Unai MD, Zoran Popovic MD, Serge C. Harb MD, Amar Krishnaswamy MD, Lars G. Svensson MD, PhD, Douglas R. Johnston MD, Samir R. Kapadia MD
doi : 10.1002/ccd.30388
Transcatheter aortic valve-in-valve implantation (ViV-TAVI) has emerged in recent years as a safe alternative to redo surgery in high-risk patients. Although early results are encouraging, data beyond short-term outcomes are lacking. Herein, we aimed to assess the 2-year outcomes after ViV-TAVI.
Validation of reliability and predictivity of membrane septum length measurements for pacemaker need after transcatheter aortic valve replacement
Hirofumi Hioki MD, Yusuke Watanabe MD, Ken Kozuma MD, Toshinobu Ryuzaki MD, Shinichi Goto MD, Taku Inohara MD, Yoshinori Katsumata MD, Tatsuya Tsunaki RT, Ryotaku Kawahata RT, Toshihiro Kobayashi RT, Masahiko Asami MD, Toshiaki Otsuka MD, Masanori Yamamoto MD, Kentaro Hayashida MD, OCEAN-TAVI Investigators
doi : 10.1002/ccd.30377
To assess the inter methodological agreement of membrane septum (MS) length measurement and additive value for risk stratification of new pacemaker implantation (PMI) over the established predictors after transcatheter aortic valve replacement (TAVR).
Membranous septum length may not be the answer
Hiroki Ueyama MD, Peter C. Block MD, MSCAI
doi : 10.1002/ccd.30456
Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI-NHR risk model
Hatem Al-Farra MD, MSc, Anita C. J. Ravelli PhD, José P. S. Henriques MD, PhD, Saskia Houterman PhD, Bas A. J. M. de Mol MD, PhD, Prof. Ameen Abu-Hanna PhD, NHR THI Registration Committee
doi : 10.1002/ccd.30398
The currently available mortality prediction models (MPM) have suboptimal performance when predicting early mortality (30-days) following transcatheter aortic valve implantation (TAVI) on various external populations. We developed and validated a new TAVI-MPM based on a large number of predictors with recent data from a national heart registry.
Real-world experience with concomitant or staged transcatheter aortic and mitral valve replacements using balloon-expandable valves
Alan Zajarias MD, Susheel Kodali MD, James M. McCabe MD, FACC, Marvin H. Eng MD, Vasilis Babaliaros MD
doi : 10.1002/ccd.30331
Transcatheter therapies for severe aortic and mitral stenosis: To stage or not to stage?
Amer Abdulla MD, Hani Jneid MD, FAHA, FSCAI
doi : 10.1002/ccd.30468
Combined aortic stenosis (AS) and mitral valve disease poses significant diagnostic and management challenges, and will likely be encountered more frequently with an aging population.
Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications
Matteo Maurina MD, Francesco Condello MD, Antonio Mangieri MD, Jorge Sanz-Sanchez MD, PhD, Giulio Giuseppe Stefanini MD, PhD, Dario Bongiovanni MD, Ottavia Cozzi MD, Pier Pasquale Leone MD, Sara Baggio MD, Gabriele Gasparini MD, Paolo Pagnotta MD, Efrem Civilini MD, Antonio Colombo MD, Bernhard Reimers MD, Damiano Regazzoli MD
doi : 10.1002/ccd.30385
To report the experience of a high-volume center with balloon-expandable (BE) stents implantation to manage vascular complications after transcatheter aortic valve replacement (TAVR).
Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy
Lauren E. Fanta MD, Steven M. Ewer MD, Giorgio Gimelli MD, Nicole M. Reilly MD
doi : 10.1002/ccd.30411
Cardiac amyloidosis can occasionally demonstrate an atypical pattern of infiltration, causing asymmetric septal thickening and a left ventricular outflow tract (LVOT) gradient with systolic anterior motion (SAM) of the mitral valve resembling obstructive hypertrophic cardiomyopathy.
Harnessing the parallax for better spatial awareness
Radosław Targoński MD, PhD, Aleksandra Gąsecka MD, PhD, Marlon S. Luis MD, Dariusz Jagielak MD, PhD, Miłosz Jaguszewski MD, PhD, Nicolo Piazza MD, PhD
doi : 10.1002/ccd.30376
Despite easy access to imaging diagnostic procedures and an abundance of spatial data, most cardiac interventions are still performed under two-dimensional fluoroscopy.
Will the TRANSFORM II trial transform our management of small vessel coronary disease?
Cindy L. Grines MD, MSCAI, Pradyumna Tummala MD, FSCAI
doi : 10.1002/ccd.30429
Peripheral studies deserve center stage!
Atul Kukar DO, FSCAI, George D. Dangas MD, MSCAI
doi : 10.1002/ccd.30430
A new frontier in left atrial appendage closure
Arun Narayanan MD, Hani Jneid MD, FAHA, FSCAI
doi : 10.1002/ccd.30431
The premise and performance of transcatheter vacuum-assisted extraction of left side cardiac thrombotic masses
On Topaz MD, FACC, FSCAI
doi : 10.1002/ccd.30432
Dual guidewire balloon for antegrade fenestration re-entry: A welcome addition to the CTO operators' armamentarium
Salman S. Allana MD, Emmanouil S. Brilakis MD, PhD
doi : 10.1002/ccd.30433
Women deserve the best care
Erika L. Jones MD, James C. Blankenship MD, MHCM, MSCAI
doi : 10.1002/ccd.30434
Local or general anesthesia for EVAR in patients with ruptured AAA?
Mehmet Cilingiroglu MD, Ibrahim Halil Inanc MD
doi : 10.1002/ccd.30436
Intravascular lithotripsy pretreatment of coronary chronic total occlusions: Current PROGRESS and the Next Frontier
Marzia Colopi MD, Giuseppe Musumeci MD
doi : 10.1002/ccd.30437
